ELITE PHARMACEUTICALS INC /NV/ Annual Cost of Revenue in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
  • Elite Pharmaceuticals Inc /Nv/ Cost of Revenue for the quarter ending June 30, 2024 was $10.3M, a 144% increase year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ Cost of Revenue for the twelve months ending June 30, 2024 was $36.4M, a 101% increase year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Cost of Revenue for 2023 was $30.3M, a 72.4% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Cost of Revenue for 2022 was $17.6M, a 0.54% increase from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Cost of Revenue for 2021 was $17.5M, a 29.3% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $30.3M +$12.7M +72.4% Apr 1, 2023 Mar 31, 2024 10-K 2024-07-01
2022 $17.6M +$94.3K +0.54% Apr 1, 2022 Mar 31, 2023 10-K 2024-07-01
2021 $17.5M +$3.95M +29.3% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-29
2020 $13.5M +$3.5M +34.9% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-29
2019 $10M +$5.31M +113% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
2018 $4.7M +$1.19M +33.9% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-30
2017 $3.51M -$2.39M -40.5% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-21
2016 $5.9M +$1.41M +31.5% Apr 1, 2016 Mar 31, 2017 10-K 2018-06-14
2015 $4.48M +$1.47M +48.8% Apr 1, 2015 Mar 31, 2016 10-K 2018-06-14
2014 $3.01M -$223K -6.88% Apr 1, 2014 Mar 31, 2015 10-K 2017-06-14
2013 $3.24M +$921K +39.8% Apr 1, 2013 Mar 31, 2014 10-K 2016-06-15
2012 $2.32M +$1.3M +128% Apr 1, 2012 Mar 31, 2013 10-K 2014-06-30
2011 $1.01M -$1.66M -62.1% Apr 1, 2011 Mar 31, 2012 10-K 2013-06-21
2010 $2.68M Apr 1, 2010 Mar 31, 2011 10-K 2012-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.